Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Cyteir Therapeutics to Participate in the Credit Suisse 30th Annual Healthcare Conference


Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that its President and Chief Executive Officer Markus Renschler, MD will participate in a presentation at the Credit Suisse 30th Annual Healthcare Conference, being held virtually on November 8, 2021, at 4:20pm ET.

A live webcast of the presentation will be available in the Investors & Media section of the Cyteir website at www.cyteir.com. A webcast replay will also be available on the website shortly after conclusion of the event for 30 days.

About Cyteir Therapeutics, Inc.

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir's wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.


These press releases may also interest you

at 02:17
MPC Energy Solutions (MPCES) has commenced construction of Parque Solar Los Girasoles, a solar photovoltaic (PV) plant in Colombia that  will supply around 23 GWh a year ? equivalent to the energy consumption of over 17,000 people. MPC Energy...

at 02:10
Mycronic AB (publ) has received an order for an SLX mask writer from an existing customer in Asia. The order value is in the range of USD 4-6 million. Delivery of the system is planned for the second quarter of 2022. The SLX laser mask writer meets...

at 02:05
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca (LSE/STO/Nasdaq: AZN) have received notification of acceptance by the U.S. Food and Drug Administration (FDA) of the supplemental Biologics License Application (sBLA) of...

at 02:05
A new study from Juniper Research has found that the value of global eCommerce payment transactions will exceed $7.5 trillion by 2026, from $4.9 trillion in 2021. This growth rate of 55% over the next five years will be driven by retailers offering...

at 02:05
Aelis Farma (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, announces the approval of its Registration Document by the Autorité des marchés financiers (AMF) under number...

at 02:03
CentralNic Group PLC (AIM: CNIC), the online marketplace for domain names and online presence and customer acquisition tools, is pleased to announce that its organic growth has further accelerated during the fourth quarter of 2021, resulting in...



News published on 1 november 2021 at 07:35 and distributed by: